Elite Pharmaceuticals Inc (ELTP)
0.1328
0.00 (0.00%)
USD |
OTCM |
Apr 26, 11:25
Elite Pharmaceuticals Cash from Operations (TTM): -2.373M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -2.373M |
| September 30, 2023 | -0.5449M |
| June 30, 2023 | 1.186M |
| March 31, 2023 | 3.339M |
| December 31, 2022 | 1.975M |
| September 30, 2022 | 5.577M |
| June 30, 2022 | 4.235M |
| March 31, 2022 | 6.508M |
| December 31, 2021 | 4.154M |
| September 30, 2021 | 2.355M |
| June 30, 2021 | 4.102M |
| March 31, 2021 | 3.194M |
| December 31, 2020 | 2.737M |
| September 30, 2020 | 1.190M |
| June 30, 2020 | -1.175M |
| March 31, 2020 | -1.794M |
| December 31, 2019 | -2.724M |
| September 30, 2019 | -3.680M |
| June 30, 2019 | -4.895M |
| March 31, 2019 | -6.793M |
| December 31, 2018 | -5.670M |
| September 30, 2018 | -4.880M |
| June 30, 2018 | -5.428M |
| March 31, 2018 | -4.809M |
| December 31, 2017 | -7.872M |
| Date | Value |
|---|---|
| September 30, 2017 | -8.120M |
| June 30, 2017 | -8.211M |
| March 31, 2017 | -7.884M |
| December 31, 2016 | -3.201M |
| September 30, 2016 | -4.259M |
| June 30, 2016 | -5.420M |
| March 31, 2016 | -2.765M |
| December 31, 2015 | -7.228M |
| September 30, 2015 | -8.050M |
| June 30, 2015 | -9.000M |
| March 31, 2015 | -15.10M |
| December 31, 2014 | -12.72M |
| September 30, 2014 | -11.57M |
| June 30, 2014 | -8.074M |
| March 31, 2014 | -4.217M |
| December 31, 2013 | -2.968M |
| September 30, 2013 | -1.838M |
| June 30, 2013 | -1.751M |
| March 31, 2013 | -1.693M |
| December 31, 2012 | -1.072M |
| September 30, 2012 | -1.304M |
| June 30, 2012 | -0.9306M |
| March 31, 2012 | -0.3941M |
| December 31, 2011 | 0.4453M |
| September 30, 2011 | 0.9677M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-4.895M
Minimum
Jun 2019
6.508M
Maximum
Mar 2022
1.230M
Average
1.975M
Median
Dec 2022
Cash from Operations (TTM) Benchmarks
| NovaBay Pharmaceuticals Inc | -4.131M |
| Palatin Technologies Inc | -26.54M |
| iBio Inc | -18.89M |
| Theriva Biologics Inc | -19.00M |
| Oragenics Inc | -7.291M |